Weitz & Luxenberg is no longer accepting Trasylol cases 

Did the anti-bleeding drug Trasylol cause you harm?

Get a free Trasylol lawsuit review when you complete the form below.

Reuters is reporting that Bayer's Trasylol drug, withdrawn from the market in November, has a 53 percent higher risk of death compared to other drugs used to reduce bleeding in high-risk heart surgery, according to long-awaited study published on May 13, 2008.

A commentary accompanying the study, released online by the New England Journal of Medicine, said the drug was unlikely to be returned to the market.

If you were given Trasylol during or after surgery and suffered kidney failure, please fill out the form below for a free Trasylol lawsuit review.

A representative of our law firm will be in touch with you shortly.

see also:

trasylol Anti-Bleeding Lawyers: Anti-Bleeding Drug Trasylol Causes Higher Risk of Death
Trasylol used to reduce bleeding causes risk of death--Free Legal Info

Trasylol Injury Risk Trasylol Pulled From Worldwide Market Amid Fear of Injury to Patients
Clotting Drug Trasylol Causes Injury to Patients--Free Lawsuit Review